Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

On March 17, 2021 Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, reported that the company will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Press release, Avid Bioservices, MAR 17, 2021, View Source [SID1234576787]). Nick Green, president and chief executive officer of Avid Bioservices, will be the featured speaker in a fireside chat at the conference, which will take place March 23-24, 2021 in a virtual format.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the company’s participation are as follows:

KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Conference Date: March 23-24, 2021
Fireside Chat Time/Date: 4:15 p.m. Eastern on Wednesday, March 24, 2021
Format: Virtual Conference